| Corgenix Medical Corporation (OTC QB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, today announced that Zacks Investment Research has initiated coverage of the company. The following summarizes the Outlook and the entire report on Corgenix will soon be available on our website, www.corgenix.com. Zack's Investment Outlook on Corgenix Medical Corporation (CONX-QB): "Corgenix is on the front-end of a transition away from reliance on certain legacy products to a...continued CONX Medical Healthcare pharmaceuticals |
Thursday, October 20, 2011
Zack's Investment Research Initiates Coverage on Corgenix Medical Corporation with "Outperform" Rating
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment